LION bioscience confirms take-over bid of Hopp family
LION bioscience received at the 6th of July the information that two investment-companies of the Hopp family, DH-Capital GmbH & Co. KG und OH Beteiligungen GmbH & Co. KG, will make a voluntary bid to acquire all shares of LION bioscience AG at a price of 1.82 per share.
This decision is to be seen before the background of the contract signed by LION bioscience AG also at the 6th of July to acquire SYGNIS Bioscience mbH & Co. KG, owned by the majority of the investment-company of the Hopp familiy. In this transaction, LION bioscience AG will pay in shares using the authorized capital of the company.
Furthermore, as both investment companies of the Hopp family committed further capital inflow into LION bioscience AG, it is to be expected that they will further increase their stake in LION.
Most read news
Organizations
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
![Precise X-ray thermometer for warm dense matter - New method for temperature determination opens horizon for a multitude of experiments virtually unfeasible up to now](https://img.chemie.de/Portal/News/63dcd9206157b_r7vEHCqhI.jpg?tr=w-1776,h-1335,cm-extract,x-123,y--3:n-xzoom)